LHC Group (NASDAQ:LHCG) was upgraded by equities researchers at BidaskClub from a “hold” rating to a “buy” rating in a report released on Friday.

Other analysts also recently issued reports about the stock. Stephens set a $69.00 price target on shares of LHC Group and gave the company a “buy” rating in a report on Saturday, May 6th. Royal Bank Of Canada reiterated a “buy” rating and issued a $69.00 price target on shares of LHC Group in a report on Tuesday, July 18th. Zacks Investment Research upgraded shares of LHC Group from a “hold” rating to a “buy” rating and set a $67.00 price target on the stock in a report on Saturday, August 5th. Jefferies Group LLC reiterated a “buy” rating and issued a $68.00 price target on shares of LHC Group in a report on Friday, August 4th. Finally, Benchmark Co. lifted their price target on shares of LHC Group from $63.00 to $72.00 and gave the company a “buy” rating in a report on Thursday, June 8th. Nine investment analysts have rated the stock with a buy rating, LHC Group presently has a consensus rating of “Buy” and an average target price of $65.75.

LHC Group (NASDAQ LHCG) traded up 0.70% on Friday, hitting $64.31. 97,793 shares of the stock were exchanged. LHC Group has a 12 month low of $32.04 and a 12 month high of $69.35. The firm has a market cap of $1.18 billion, a P/E ratio of 28.46 and a beta of 0.77. The company has a 50-day moving average of $63.27 and a 200 day moving average of $57.46.

LHC Group (NASDAQ:LHCG) last announced its quarterly earnings results on Wednesday, August 2nd. The health services provider reported $0.63 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.09. The company had revenue of $260.20 million for the quarter, compared to the consensus estimate of $254.10 million. LHC Group had a net margin of 4.13% and a return on equity of 9.62%. LHC Group’s revenue for the quarter was up 15.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.52 EPS. Equities research analysts expect that LHC Group will post $2.39 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This piece was reported by American Banking News and is owned by of American Banking News. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of U.S. and international copyright & trademark laws. The legal version of this piece can be read at https://www.americanbankingnews.com/2017/08/18/lhc-group-lhcg-stock-rating-upgraded-by-bidaskclub.html.

In other LHC Group news, Director Coliseum Capital Management, L sold 14,450 shares of LHC Group stock in a transaction on Friday, June 16th. The shares were sold at an average price of $65.69, for a total value of $949,220.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Donald Dwayne Stelly sold 3,181 shares of LHC Group stock in a transaction on Thursday, June 8th. The stock was sold at an average price of $64.97, for a total transaction of $206,669.57. Following the completion of the transaction, the chief operating officer now directly owns 114,235 shares of the company’s stock, valued at $7,421,847.95. The disclosure for this sale can be found here. Insiders sold a total of 546,207 shares of company stock valued at $33,813,733 over the last three months. Corporate insiders own 14.80% of the company’s stock.

Several institutional investors have recently modified their holdings of the company. Federated Investors Inc. PA boosted its position in shares of LHC Group by 4.2% in the second quarter. Federated Investors Inc. PA now owns 1,622 shares of the health services provider’s stock worth $110,000 after buying an additional 66 shares during the last quarter. Acrospire Investment Management LLC boosted its position in shares of LHC Group by 30.8% in the second quarter. Acrospire Investment Management LLC now owns 1,700 shares of the health services provider’s stock worth $115,000 after buying an additional 400 shares during the last quarter. Cubist Systematic Strategies LLC boosted its position in shares of LHC Group by 758.0% in the second quarter. Cubist Systematic Strategies LLC now owns 1,716 shares of the health services provider’s stock worth $116,000 after buying an additional 1,516 shares during the last quarter. First Mercantile Trust Co. acquired a new position in shares of LHC Group during the second quarter worth approximately $147,000. Finally, Invictus RG acquired a new position in shares of LHC Group during the first quarter worth approximately $125,000. 84.95% of the stock is owned by institutional investors and hedge funds.

LHC Group Company Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.